SEARCH

SEARCH BY CITATION

References

  • 1
    Bosch FX,Ribes J,Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999; 19: 27185.
  • 2
    Parkin DM,Pisani P,Ferlay J. Global cancer statistics. CA Cancer J Clin 1999; 49: 3364,1.
  • 3
    Anzola M,Cuevas N,Lopez-Martinez M,Martinez de Pancorbo M,Burgos JJ. Patterns of methylation profiles as diagnostic markers for multiple hepatocellular carcinomas. Scand J Gastroenterol 2004; 39: 24651.
  • 4
    Okuda K. Hepatocellular carcinoma: clinicopathological aspects. J Gastroenterol Hepatol 1997; 12: S31418.
  • 5
    Feitelson MA,Sun B,Satiroglu Tufan NL,Liu J,Pan J,Lian Z. Genetic mechanisms of hepatocarcinogenesis. Oncogene 2002; 21: 2593604.
  • 6
    Esteller M,Corn PG,Baylin SB,Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001; 61: 32259.
  • 7
    Jeronimo C,Usadel H,Henrique R,Oliveira J,Lopes C,Nelson WG,Sidransky D. Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. J Natl Cancer Inst 2001; 93: 174752.
  • 8
    Esteller M,Sparks A,Toyota M,Sanchez-Cespedes M,Capella G,Peinado MA,Gonzalez S,Tarafa G,Sidransky D,Meltzer SJ,Baylin SB,Herman JG. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 2000; 60: 436671.
  • 9
    Baylin SB,Herman JG,Graff JR,Vertino PM,Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998; 72: 14196.
  • 10
    Li X,Hui AM,Sun L,Hasegawa K,Torzilli G,Minagawa M,Takayama T,Makuuchi M. p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma. Clin Cancer Res 2004; 10: 74849.
  • 11
    Kaneto H,Sasaki S,Yamamoto H,Itoh F,Toyota M,Suzuki H,Ozeki I,Iwata N,Ohmura T,Satoh T,Karino Y,Toyota J,Satoh M, et al. Detection of hypermethylation of the p16INK4A gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus. Gut 2001; 48: 3727.
  • 12
    Yang B,Guo M,Herman JG,Clark DP. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 2003; 163: 11017.
  • 13
    Issa JP,Ottaviano YL,Celano P,Hamilton SR,Davidson NE,Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994; 7: 53640.
  • 14
    Post WS,Goldschmidt-Clermont PJ,Wilhide CC,Heldman AW,Sussman MS,Ouyang P,Milliken EE,Issa JP. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 1999; 43: 98591.
  • 15
    Usadel H,Brabender J,Danenberg KD,Jeronimo C,Harden S,Engles J,Danenberg PV,Yang S,Sidransky D. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res 2002; 62: 3715.
  • 16
    Tsuchiya T,Tamura G,Sato K,Endoh Y,Sakata K,Jin Z,Motoyama T,Usuba O,Kimura W,Nishizuka S,Wilson KT,James SP,Yin J,Fleisher AS,Zou T,Silverberg SG,Kong D,Meltzer SJ. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene 2000; 19: 36426.
  • 17
    Kawakami K,Ruszkiewicz A,Bennett G,Moore J,Grieu F,Watanabe G,Iacopetta B. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer. Br J Cancer 2006; 94: 5938.
  • 18
    Herman JG,Graff JR,Myohanen S,Nelkin BD,Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 98216.
  • 19
    Heid CA,Stevens J,Livak KJ,Williams PM. Real time quantitative PCR. Genome Res 1996; 6: 98694.
  • 20
    Holland PM,Abramson RD,Watson R,Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′–3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 1991; 88: 727680.
  • 21
    Wong IH,Lo YM,Zhang J,Liew CT,Ng MH,Wong N,Lai PB,Lau WY,Hjelm NM,Johnson PJ. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res 1999; 59: 713.
  • 22
    Singal R,van Wert J,Bashambu M. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells. Cancer Res 2001; 61: 48206.
  • 23
    Wong IH,Ng MH,Lee JC,Lo KW,Chung YF,Huang DP. Transcriptional silencing of the p16 gene in human myeloma-derived cell lines by hypermethylation. Br J Haematol 1998; 103: 16875.
  • 24
    Sanchez-Cespedes M,Esteller M,Wu L,Nawroz-Danish H,Yoo GH,Koch WM,Jen J,Herman JG,Sidransky D. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 2000; 60: 8925.
  • 25
    Lee S,Lee HJ,Kim JH,Lee HS,Jang JJ,Kang GH. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am J Pathol 2003; 163: 13718.
  • 26
    Lehmann U,Berg-Ribbe I,Wingen LU,Brakensiek K,Becker T,Klempnauer J,Schlegelberger B,Kreipe H,Flemming P. Distinct methylation patterns of benign and malignant liver tumors revealed by quantitative methylation profiling. Clin Cancer Res 2005; 11: 365460.
  • 27
    Shen L,Ahuja N,Shen Y,Habib NA,Toyota M,Rashid A,Issa JP. DNA methylation and environmental exposures in human hepatocellular carcinoma. J Natl Cancer Inst 2002; 94: 75561.
  • 28
    Piotrowski A,Benetkiewicz M,Menzel U,de Stahl TD,Mantripragada K,Grigelionis G,Buckley PG,Jankowski M,Hoffman J,Bala D,Srutek E,Laskowski R, et al. Microarray-based survey of CpG islands identifies concurrent hyper- and hypomethylation patterns in tissues derived from patients with breast cancer. Genes Chromosomes Cancer 2006; 45: 65667.
  • 29
    Riggs AD,Pfeifer GP. X-chromosome inactivation and cell memory. Trends Genet 1992; 8: 16974.
  • 30
    Fackler MJ,McVeigh M,Mehrotra J,Blum MA,Lange J,Lapides A,Garrett E,Argani P,Sukumar S. Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res 2004; 64: 444252.
  • 31
    Jeronimo C,Usadel H,Henrique R,Silva C,Oliveira J,Lopes C,Sidransky D. Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer. Urology 2002; 60: 11315.
  • 32
    Hanson JA,Gillespie JW,Grover A,Tangrea MA,Chuaqui RF,Emmert-Buck MR,Tangrea JA,Libutti SK,Linehan WM,Woodson KG. Gene promoter methylation in prostate tumor-associated stromal cells. J Natl Cancer Inst 2006; 98: 25561.
  • 33
    Zhang YJ,Chen Y,Ahsan H,Lunn RM,Lee PH,Chen CJ,Santella RM. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma. Int J Cancer 2003; 103: 4404.
  • 34
    Matsukura S,Soejima H,Nakagawachi T,Yakushiji H,Ogawa A,Fukuhara M,Miyazaki K,Nakabeppu Y,Sekiguchi M,Mukai T. CpG methylation of MGMT and hMLH1 promoter in hepatocellular carcinoma associated with hepatitis viral infection. Br J Cancer 2003; 88: 5219.
  • 35
    Enokida H,Shiina H,Urakami S,Igawa M,Ogishima T,Pookot D,Li LC,Tabatabai ZL,Kawahara M,Nakagawa M,Kane CJ,Carroll PR, et al. Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer. Int J Cancer 2005; 116: 17481.
  • 36
    Bakker J,Lin X,Nelson WG. Methyl-CpG binding domain protein 2 represses transcription from hypermethylated π-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells. J Biol Chem 2002; 277: 2257380.
  • 37
    Zhong S,Tang MW,Yeo W,Liu C,Lo YM,Johnson PJ. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. Clin Cancer Res 2002; 8: 108792.
  • 38
    Sherman M,Peltekian KM,Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995; 22: 4328.
  • 39
    Wong IH,Zhang J,Lai PB,Lau WY,Lo YM. Quantitative analysis of tumor-derived methylated p16INK4a sequences in plasma, serum, and blood cells of hepatocellular carcinoma patients. Clin Cancer Res 2003; 9: 104752.